HK1200710A1 - 膽鹼組合物 - Google Patents
膽鹼組合物Info
- Publication number
- HK1200710A1 HK1200710A1 HK15101177.6A HK15101177A HK1200710A1 HK 1200710 A1 HK1200710 A1 HK 1200710A1 HK 15101177 A HK15101177 A HK 15101177A HK 1200710 A1 HK1200710 A1 HK 1200710A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- choline composition
- choline
- composition
- Prior art date
Links
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 title 1
- 229960001231 choline Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161626928P | 2011-10-05 | 2011-10-05 | |
| PCT/US2012/000481 WO2013052117A1 (en) | 2011-10-05 | 2012-10-04 | Choline composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1200710A1 true HK1200710A1 (zh) | 2015-08-14 |
Family
ID=48044056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15101177.6A HK1200710A1 (zh) | 2011-10-05 | 2015-02-04 | 膽鹼組合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9216160B2 (zh) |
| EP (1) | EP2763682B1 (zh) |
| CA (1) | CA2850919C (zh) |
| ES (1) | ES2660118T3 (zh) |
| HK (1) | HK1200710A1 (zh) |
| PL (1) | PL2763682T3 (zh) |
| WO (1) | WO2013052117A1 (zh) |
| ZA (1) | ZA201402990B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104853734B (zh) * | 2012-12-20 | 2020-05-22 | 高露洁-棕榄公司 | 含有离子性液体的口腔护理组合物 |
| SE540582C2 (en) * | 2016-12-22 | 2018-10-02 | Scandibio Therapeutics Ab | Substances for treatment of fatty liver-related conditions |
| US11446253B2 (en) | 2017-11-17 | 2022-09-20 | President And Fellows Of Harvard College | Ionic liquids for internal delivery |
| US11684594B2 (en) | 2020-05-12 | 2023-06-27 | President And Fellows Of Harvard College | Antifungal prophylaxis for cornea |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1159615A (en) | 1966-05-16 | 1969-07-30 | Vivonex Corp | A Nutritionally Adequate, Non-Residual Dietary Composition for the reduction of the Intestinal Microflora Level |
| US4237118A (en) | 1972-03-06 | 1980-12-02 | Howard Alan N | Dietary supplement and dietary methods employing said supplement for the treatment of obesity |
| US4911917A (en) * | 1988-06-28 | 1990-03-27 | Hauser-Kuhrts, Inc. | Cholesterol-lowering combination comopsitions of magnesium salt and niacin |
| US5268181A (en) | 1989-04-13 | 1993-12-07 | Upsher-Smith Laboratories, Inc. | Method of using niacin to control nocturnal cholesterol synthesis |
| US5084482A (en) | 1990-04-10 | 1992-01-28 | The Lithox Corporation | Methods for inhibiting inflammatory ischemic, thrombotic and cholesterolemic disease response with methionine compounds |
| US5215750A (en) | 1991-09-04 | 1993-06-01 | Keane Ii Michael A | L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control |
| CA2057463C (en) | 1991-12-11 | 1998-10-27 | David Rowland | Vitamin/mineral composition |
| JPH0624977A (ja) | 1992-07-10 | 1994-02-01 | Rikagaku Kenkyusho | 抗肥満剤及び抗高脂血症剤 |
| US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| US5597585A (en) | 1995-12-26 | 1997-01-28 | Williams; Andrew H. | Vitamin/mineral composition |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| WO1999065337A1 (en) | 1998-06-19 | 1999-12-23 | Beth Israel Deaconess Medical Center | Dietary supplement for post-menopausal women |
| US20040043013A1 (en) * | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
| US20070196496A1 (en) * | 2002-04-16 | 2007-08-23 | Michael Farber | Delivery systems for functional ingredients |
| FR2851425A1 (fr) | 2003-02-21 | 2004-08-27 | Oligocaps Lab | Complement nutritionnel a base de chitosan ayant une composition original sous diverses formes galeniques |
| CZ294623B6 (cs) | 2003-05-30 | 2005-02-16 | Jiří Mudr. Polák | Léčivo k prevenci a léčení obezity |
| US7875291B1 (en) | 2003-09-05 | 2011-01-25 | Glu-Pro, Inc. | Composition for managing diabetes, obesity, and hyperlipidemia and associated methods |
| US20060009486A1 (en) | 2004-07-07 | 2006-01-12 | Gm Pharmaceuticals Inc. | Composition and method for treatment and prevention of coronary artery disease |
| US7304044B2 (en) | 2005-01-11 | 2007-12-04 | Jarowski Charles I | Lowering blood glucose, urea, cholesterol, triglycerides and normalizing homocysteine levels by dietary addition of selected essential amino acids and three vitamins |
| US20070037818A1 (en) | 2005-08-15 | 2007-02-15 | Livingston William H | Discovery of valuable properties for the primary energy source "PES 2000 plus Folic Acid" |
| US20070065456A1 (en) | 2005-09-20 | 2007-03-22 | Woods Cindy J | Nutritional supplements |
| US20070105793A1 (en) | 2005-11-04 | 2007-05-10 | Curt Hendrix | Compositions and methods using nicotinic acid for treatment of hypercholesterolemia, hyperlipidemia nd cardiovascular disease |
| KR20070063350A (ko) | 2005-12-14 | 2007-06-19 | 주식회사종근당 | 서방형 방출층과 속방형 방출층을 포함한 고지혈증 및동맥경화를 치료를 위한 약제학적 조성물 |
| US7989009B2 (en) | 2006-02-02 | 2011-08-02 | Advocare International, L.P. | Composition and method for promoting weight loss |
| EP1859690A1 (en) | 2006-05-26 | 2007-11-28 | Health Concern B.V. | Premix for cholesterol lowering food products |
| EP1897451A1 (en) | 2006-09-08 | 2008-03-12 | SHS International Ltd. | Tasteless nutritional supplement containing free amino acids |
| DE102007004781A1 (de) * | 2007-01-31 | 2008-08-07 | Alzchem Trostberg Gmbh | Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels |
| US20080268038A1 (en) | 2007-04-26 | 2008-10-30 | Wolfe Robert R | Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength |
| US20100021573A1 (en) | 2008-07-22 | 2010-01-28 | Michael J Gonzalez | Compositions and methods for the prevention of cardiovascular disease |
| US20100080856A1 (en) | 2008-09-26 | 2010-04-01 | Costantino Peter D | Method and composition for postoperative wound healing |
| CN101721421A (zh) | 2009-12-31 | 2010-06-09 | 无锡美泰生物科技有限公司 | 一种治疗肥胖症的鼻腔鼻窦用药及其制备方法 |
-
2012
- 2012-10-04 WO PCT/US2012/000481 patent/WO2013052117A1/en active Application Filing
- 2012-10-04 PL PL12839027T patent/PL2763682T3/pl unknown
- 2012-10-04 CA CA2850919A patent/CA2850919C/en active Active
- 2012-10-04 ES ES12839027.5T patent/ES2660118T3/es active Active
- 2012-10-04 EP EP12839027.5A patent/EP2763682B1/en active Active
- 2012-10-04 US US13/261,836 patent/US9216160B2/en active Active
-
2014
- 2014-04-24 ZA ZA2014/02990A patent/ZA201402990B/en unknown
-
2015
- 2015-02-04 HK HK15101177.6A patent/HK1200710A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2660118T3 (es) | 2018-03-20 |
| US20150164828A1 (en) | 2015-06-18 |
| EP2763682B1 (en) | 2017-11-22 |
| EP2763682A1 (en) | 2014-08-13 |
| EP2763682A4 (en) | 2015-06-03 |
| WO2013052117A1 (en) | 2013-04-11 |
| CA2850919A1 (en) | 2013-04-11 |
| CA2850919C (en) | 2017-01-17 |
| PL2763682T3 (pl) | 2018-06-29 |
| ZA201402990B (en) | 2016-08-31 |
| US9216160B2 (en) | 2015-12-22 |
| AU2012319112A1 (en) | 2014-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201308399B (en) | Improved composition | |
| EP2730619A4 (en) | COMPOSITION | |
| HRP20181667T1 (hr) | Pripravak | |
| EP2692796A4 (en) | COMPOSITION | |
| GB201120616D0 (en) | Composition | |
| IL231660A0 (en) | preparation | |
| GB201119601D0 (en) | Composition | |
| HK1200710A1 (zh) | 膽鹼組合物 | |
| HK1201029A1 (zh) | 組合物 | |
| GB201121258D0 (en) | Composition | |
| GB201108912D0 (en) | Composition | |
| GB201103964D0 (en) | Composition | |
| GB201204957D0 (en) | Composition | |
| GB201115211D0 (en) | Composition | |
| ZA201309110B (en) | Composition | |
| GB201216884D0 (en) | Composition | |
| ZA201203742B (en) | Nutricosmetic composition | |
| GB201322023D0 (en) | Composition | |
| EP2711011A4 (en) | PANAXADIUM-CONTAINING COMPOSITION | |
| GB201118701D0 (en) | Composition | |
| GB201118516D0 (en) | Composition | |
| GB201117232D0 (en) | Composition | |
| GB201116970D0 (en) | Composition | |
| GB201116817D0 (en) | Composition | |
| GB201116433D0 (en) | Composition |